meddevicedb.com FDA Device Reference

ACA CONJUGATED BILIRUBIN ANALYTICAL

K842385 Class II Traditional
Decision Date
1984-08-17
Sponsor / Applicant
E.I. Dupont DE Nemours & Co., Inc.

Technical Specification

510(k) Submission ID K842385
Product Code CIG
Medical Specialty / Panel Clinical Chemistry
Regulation Citation 21 CFR 862.1110
Decision Date 1984-08-17
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

ACA CONJUGATED BILIRUBIN ANALYTICAL received FDA 510(k) clearance under submission number K842385, sponsored by E.I. Dupont DE Nemours & Co., Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 1984-08-17.

Classification & Regulation

This clearance is catalogued under FDA product code CIG and 21 CFR 862.1110, within the Clinical Chemistry review panel as a Class II device.